rs3816873

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001386140.1(MTTP):​c.383T>C​(p.Ile128Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.257 in 1,613,128 control chromosomes in the GnomAD database, including 55,034 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 5382 hom., cov: 32)
Exomes 𝑓: 0.26 ( 49652 hom. )

Consequence

MTTP
NM_001386140.1 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.741

Publications

81 publications found
Variant links:
Genes affected
MTTP (HGNC:7467): (microsomal triglyceride transfer protein) MTP encodes the large subunit of the heterodimeric microsomal triglyceride transfer protein. Protein disulfide isomerase (PDI) completes the heterodimeric microsomal triglyceride transfer protein, which has been shown to play a central role in lipoprotein assembly. Mutations in MTP can cause abetalipoproteinemia. [provided by RefSeq, Jul 2008]
MTTP Gene-Disease associations (from GenCC):
  • abetalipoproteinemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, PanelApp Australia, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.649328E-4).
BP6
Variant 4-99583507-T-C is Benign according to our data. Variant chr4-99583507-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 14242.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.333 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTTPNM_001386140.1 linkc.383T>C p.Ile128Thr missense_variant Exon 3 of 18 ENST00000265517.10 NP_001373069.1
MTTPNM_000253.4 linkc.383T>C p.Ile128Thr missense_variant Exon 4 of 19 NP_000244.2 P55157-1
MTTPNM_001300785.2 linkc.134T>C p.Ile45Thr missense_variant Exon 3 of 18 NP_001287714.2 P55157B7Z7X3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTTPENST00000265517.10 linkc.383T>C p.Ile128Thr missense_variant Exon 3 of 18 1 NM_001386140.1 ENSP00000265517.5 P55157-1

Frequencies

GnomAD3 genomes
AF:
0.262
AC:
39787
AN:
151904
Hom.:
5374
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.278
Gnomad AMI
AF:
0.488
Gnomad AMR
AF:
0.238
Gnomad ASJ
AF:
0.399
Gnomad EAS
AF:
0.146
Gnomad SAS
AF:
0.349
Gnomad FIN
AF:
0.190
Gnomad MID
AF:
0.335
Gnomad NFE
AF:
0.260
Gnomad OTH
AF:
0.297
GnomAD2 exomes
AF:
0.248
AC:
61707
AN:
248600
AF XY:
0.255
show subpopulations
Gnomad AFR exome
AF:
0.272
Gnomad AMR exome
AF:
0.160
Gnomad ASJ exome
AF:
0.408
Gnomad EAS exome
AF:
0.137
Gnomad FIN exome
AF:
0.189
Gnomad NFE exome
AF:
0.259
Gnomad OTH exome
AF:
0.273
GnomAD4 exome
AF:
0.257
AC:
374829
AN:
1461106
Hom.:
49652
Cov.:
35
AF XY:
0.260
AC XY:
189092
AN XY:
726840
show subpopulations
African (AFR)
AF:
0.282
AC:
9422
AN:
33458
American (AMR)
AF:
0.168
AC:
7532
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.398
AC:
10399
AN:
26120
East Asian (EAS)
AF:
0.152
AC:
6029
AN:
39656
South Asian (SAS)
AF:
0.342
AC:
29458
AN:
86228
European-Finnish (FIN)
AF:
0.188
AC:
9999
AN:
53152
Middle Eastern (MID)
AF:
0.352
AC:
2030
AN:
5764
European-Non Finnish (NFE)
AF:
0.255
AC:
283730
AN:
1111638
Other (OTH)
AF:
0.269
AC:
16230
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
14871
29742
44613
59484
74355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9634
19268
28902
38536
48170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.262
AC:
39818
AN:
152022
Hom.:
5382
Cov.:
32
AF XY:
0.261
AC XY:
19359
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.278
AC:
11525
AN:
41490
American (AMR)
AF:
0.237
AC:
3619
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.399
AC:
1385
AN:
3472
East Asian (EAS)
AF:
0.146
AC:
757
AN:
5178
South Asian (SAS)
AF:
0.347
AC:
1672
AN:
4818
European-Finnish (FIN)
AF:
0.190
AC:
2007
AN:
10566
Middle Eastern (MID)
AF:
0.337
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
0.260
AC:
17682
AN:
67922
Other (OTH)
AF:
0.298
AC:
627
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1509
3019
4528
6038
7547
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
422
844
1266
1688
2110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.264
Hom.:
21115
Bravo
AF:
0.261
TwinsUK
AF:
0.254
AC:
940
ALSPAC
AF:
0.271
AC:
1043
ESP6500AA
AF:
0.272
AC:
1197
ESP6500EA
AF:
0.258
AC:
2218
ExAC
AF:
0.249
AC:
30226
Asia WGS
AF:
0.291
AC:
1008
AN:
3478
EpiCase
AF:
0.270
EpiControl
AF:
0.265

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jan 05, 2020
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 09, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

not provided Benign:3
Aug 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 21438662, 16617174, 16721486, 30782561, 33111339) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Abetalipoproteinaemia Benign:2
Nov 19, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

METABOLIC SYNDROME, PROTECTION AGAINST Benign:1
Jan 01, 2006
OMIM
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Abetalipoproteinaemia;C4552048:Metabolic syndrome X Benign:1
Mar 11, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
17
DANN
Benign
0.69
DEOGEN2
Benign
0.011
T;.;T;T;.
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.085
N
LIST_S2
Benign
0.71
T;T;.;T;T
MetaRNN
Benign
0.00056
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.3
.;.;L;L;L
PhyloP100
0.74
PrimateAI
Benign
0.34
T
PROVEAN
Benign
0.71
N;N;N;N;N
REVEL
Benign
0.070
Sift
Benign
0.64
T;T;T;T;T
Sift4G
Benign
0.22
T;T;T;T;T
Polyphen
0.0020, 0.0
.;B;B;B;.
Vest4
0.026, 0.018, 0.017, 0.027
MPC
0.30
ClinPred
0.0061
T
GERP RS
4.1
Varity_R
0.074
gMVP
0.24
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3816873; hg19: chr4-100504664; COSMIC: COSV55504606; COSMIC: COSV55504606; API